Feed Articles

3 stocks whose trading volume is giving them a new direction

In the markets, we often hear about indicators, charts and trend lines to help investors make decisions. But what gets lost in this deluge of data is the very foundation - trading volume. For it is volume that reveals the market's true beliefs about the price movement of a stock or ETF, and those who understand this factor have an edge over others.

Call option volume is a particularly interesting indicator because it provides important information about expected price movements. Investors betting on call options are showing their confidence in growth. This article will focus on three stocks where trading volume signals potential growth: Cameco as a bet on nuclear power, Pfizer as an undervalued healthcare giant, and regional banks benefiting from interest rate changes.

Cameco: The future of energy

With the growing demand for technological innovations such as artificial intelligence and quantum computing, the issue of sustainable energy is becoming more pressing. Nuclear power, which can cope with demanding energy requirements, is thus coming to the fore.

As a key player in the uranium sector, Cameco $CCJ has seen a significant increase in call options trading, reaching a volume of 384,705 contracts. These numbers indicate strong investor confidence in the company's future growth. Moreover, Wall Street analysts estimate a target price of $66.6 per share, representing a potential upside of tens of percent.

Further evidence of growing confidence is the 9.3% decline in short positions over the past month, suggesting that investors are retreating from a bearish stance.

Pfizer: a healthcare giant at a bargain price

Shares of Pfizer $PFE are currently trading at a significant discount to their 2022 highs. With a price-to-book (P/B) ratio of 1.7x compared to the sector average of 4.8x, Pfizer is a clear opportunity for value investors.

Call options on Pfizer reached a volume of 201,090 contracts in December 2024, well above the average. This increase suggests an impending catalyst that could support share price growth. Analysts at Guggenheim maintain a Buy rating with a target price of $33 per share, representing a potential upside of 25%.

Similar to Cameco, there was a decrease in short positions, specifically by 5.5%, confirming investor optimism about the future.

Regional banks: Profit from interest rate cuts

The Federal Reserve (Fed) has begun a cycle of interest rate cuts, bringing new opportunities for regional banks. Lower rates are boosting consumer lending such as mortgages, credit cards and auto loans, which can increase the profitability of these banks.

An ETF focused on regional banks, the SPDR S&P Regional Banking ETF $KRE, is seeing increased call option activity, indicating investor confidence in the sector's growth. In addition, the ETF offers a dividend yield of 2.42%, adding appeal for long-term investors.

Disclaimer: There is plenty of inspiration to be found on Bulios, however, stock selection and portfolio construction is entirely up to you, so always conduct thorough self-analysis.

Source: Marketbeat

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 6h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy